ORG Wealth Partners’s Neuropace NPCE Stock Holding History

ORG Wealth Partners’s Portfolio NPCE Stock Details NPCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$247	Buy	+18	New	+$267	﹤0.01%	2303

Other funds holding NPCE

Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

ORG Wealth Partners's NPCE Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Neuropace (NPCE) in Q3 2026: 18 shares worth $247. The stake represents ﹤0.01% of the portfolio and ranks #2303 among its holdings.

15 funds tracked by Wall St. Rank hold NPCE as of Q3 2026.

ORG Wealth Partners held 18 shares of Neuropace worth $247 as of Q3 2026.
Neuropace was a new ORG Wealth Partners position in Q3 2026.
Neuropace made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2303 holding.
15 funds tracked by Wall St. Rank held Neuropace as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.